North China Pharmaceutical Company Ltd. Class ASSE: 600812

"North China Pharmaceutical Company Ltd."Semi-annual Report for 2026

Aug 22, 2026 · Issued by North China Pharmaceutical Company Ltd. Class A via Shanghai Stock Exchange

Semi-annual Report for 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Earlier from North China Pharmaceutical Company Ltd. Class A

"North China Pharmaceutical Company, Ltd."Announcement on Resignation of Senior ManagementAug 6
"North China Pharmaceutical Company Ltd."Announcement on the Proposed Selection of Drugs of the Company and Its Subsidiaries in the National Centralized Drug ProcurementAug 4
"North China Pharmaceutical Company.Ltd"Announcement on Inclusion of Products of the Company and Its Subsidiaries in the National Essential Medicines ListJul 11
Announcement on Obtaining Drug Registration CertificateJun 24

All North China Pharmaceutical Company Ltd. Class A news releases